Can TMS Be a Bridge When Medication Isn’t Working?

Sam Clinch • December 11, 2025

What is “treatment-resistant depression” (TRD)?



Clinically, TRD is commonly defined as depression that has not sufficiently responded to an adequate trial of two different antidepressants (from at least two different classes) given at therapeutic doses and durations. Some insurers and clinical guidelines use this “two-trial” rule when deciding whether to cover advanced treatments like TMS. Medicare and commercial payers may have slightly different wording (for example, Medicare sometimes requires one failed antidepressant; Anthem often requires two). The key idea is consistent: TRD means standard medication strategies haven’t produced an acceptable response.

Why do medications sometimes fail?



Antidepressants help many people, but there are several reasons they may not work for someone:



  • Different biology: Antidepressants act primarily on neurotransmitter systems (serotonin, norepinephrine, dopamine). Depression is heterogeneous - for some people, symptoms reflect maladaptive brain-circuit function that medications don’t adequately correct.


  • Side effects & tolerability: Some people cannot tolerate the side effects of medications at effective doses.


  • Partial or transient responses: A medication may help a little (or briefly) but not produce sustained remission.


  • Complex or comorbid conditions: Co-occurring anxiety, PTSD, medical conditions or bipolar spectrum features can blunt medication response.



Because these issues are common, clinicians consider alternative mechanisms of treatment - therapies that act on the brain in different ways. TMS is one of those options. (Ketamine/esketamine is another; the treatments can be complementary rather than mutually exclusive.)


How is TMS different from medication?




TMS uses a magnetic coil placed over the scalp to directly stimulate specific cortical regions (commonly the dorsolateral prefrontal cortex for depression). Repeated stimulation over days to weeks produces enduring changes in brain circuits (neuroplasticity), helping underactive networks regain healthier patterns. This circuit-based approach is biologically distinct from the way antidepressants modulate neurochemistry, which is one reason TMS can help people whose depression did not respond to medications. TMS is non-invasive, performed outpatients, and does not produce systemic medication side effects.

Evidence: Does TMS help people with TRD?



Yes. Large trials and many real-world clinic outcomes show that TMS can produce meaningful responses and remission in patients with TRD. Clinic-level tracking at Inspire and published meta-analyses report robust response rates among patients who previously failed multiple medication trials. Importantly, many people who respond to an initial TMS course will also benefit from retreatment or maintenance if symptoms recur - so TMS can be both an acute and a long-term tool. 

What does a TMS care pathway typically look like?



  • Consultation & screening. A TMS-trained psychiatrist reviews your history, past medication trials, suicidality risk, and safety (metal implants, seizure history). Clinics usually collect objective symptom measures (PHQ-9) to track progress.


  • Mapping & first session. The physician performs a mapping procedure to find the ideal stimulation site and the right intensity for you. The first treatment often follows mapping.



  • Monitoring & maintenance. Progress is tracked and, if needed, maintenance or booster sessions are offered to sustain benefit. Clinics also discuss integrating medication/therapy as part of ongoing care. 



Safety & tolerability - what to expect


TMS is generally well tolerated. The most common side effects are transient scalp tenderness or mild headache. Serious events (like seizure) are very rare when screening is done correctly. TMS is routinely favored for patients seeking non-systemic treatment without anesthesia, and clinics explicitly compare its safety and tolerability favorably to more invasive neuromodulation like ECT. Nonetheless, careful screening and ongoing monitoring are standard. 


Where TMS fits with other advanced options (ketamine, ECT, residential)


Ketamine / Spravato:

These can provide rapid relief for some patients and are useful in crisis or when rapid reduction of suicidal ideation is needed. However, effects may be transient for some people. TMS can be complementary - ketamine for rapid rescue and TMS for durable circuit retraining. Clinicians often design a sequence or combine approaches depending on needs.


ECT:

Still the most effective option for some severe, refractory depressions, but it requires anesthesia and carries additional recovery considerations. TMS is a less invasive option with an excellent tolerability profile and can be considered for those reluctant to pursue ECT. A clinician will help weigh risks/benefits.


Residential care:

Important for stabilization and intensive psychotherapy. If symptoms persist after residential treatment, TMS is a logical brain-directed next step to consolidate gains or treat residual biological symptoms. 

Who is most likely to benefit?


People with clearly documented TRD - those who have tried adequate antidepressant courses (and often psychotherapy) without sufficient response - are primary candidates. Partial responders to other treatments, people unable to tolerate medication side effects, or those who prefer a non-drug intervention are also common candidates. Adolescents (age 15+) may be considered in selected circumstances with careful evaluation. A psychiatrist experienced in TMS will determine candidacy after a comprehensive review. 


Download Your Roadmap to TMS


Want a clear picture of what to expect? Download the TMS Treatment Roadmap by Sydney


What about insurance & access?


Most major commercial insurers, Medicare and Tricare cover TMS for treatment-resistant major depressive disorder when plan criteria are met and prior authorization is obtained. Coverage details vary - insurers typically require documentation of medication trials, severity measures (PHQ-9), and a psychiatrist’s letter of medical necessity. Accelerated protocols and off-label indications (some anxiety/PTSD uses) are often not covered; clinics offer sliding-scale or self-pay options for those cases. Always ask the clinic to run a benefits check and provide an itemized estimate.

Patient stories & real-world hope


Clinic reviews and patient accounts often describe people who finally achieved meaningful recovery with TMS after long medication trials, ketamine courses, or residential stays. These stories don’t guarantee outcomes, but they reflect clinical experience: TMS can produce substantial, durable improvements for many people who have struggled for years. Inspire’s outcome tracking supports these real-world successes.

How to explore TMS as a bridge (practical next steps)



  1. Collect your treatment history. List antidepressants tried (names/dates/doses), any ketamine/Spravato treatments, psychotherapies and residential programs, and recent symptom scores (PHQ-9).
  2. Request a TMS consult. A TMS psychiatrist will review your record, screen for safety, and explain likely benefits and realistic expectations. Inspire offers phone consultations and runs benefits checks.
  3. Discuss sequencing. If you’ve had recent ketamine or other interventions, ask how TMS could be sequenced or combined to maximize durability of benefit.
  4. Plan for mapping & course. If you proceed, expect a mapping session and a personalized plan (standard, iTBS or accelerated) with clear monitoring and a maintenance strategy if you respond. 



Learn More: TMS Therapy


  • I tried many meds and ketamine without lasting benefit. Should I try TMS?

    Yes - different biological mechanisms mean TMS can work when other treatments did not. A TMS psychiatrist can assess your history and recommend a personalized plan.

  • How soon will I feel better?

    Responses vary. Some patients notice improvements in 1–3 weeks; many reach substantial benefit by 6–8 weeks. Accelerated protocols may speed effects for selected patients.

  • Is TMS safe if I’ve had ECT or ketamine?

    TMS can be used after other treatments, including ECT and ketamine, but decisions depend on your clinical history. Your psychiatrist will assess safety and sequencing.

Every Question Answered

Want to know more about TMS? Check out this in-depth guide to TMS therapy with transparent and easy to understand explanations about TMS processes, protocols, and treated conditions.

Latest Posts

A smiling medical professional in blue scrubs stands in front of an Inspire TMS Denver sign in an office setting.
By Sam Clinch April 13, 2026
When you’re researching TMS clinics, you’ll see different brand names and device types - MagVenture , NeuroStar, “Deep TMS” (H-coil), and more. That variety can feel confusing, so here’s a plain-language explanation of what the differences mean for you and the smart questions to ask before you book. The short version Device choice mostly affects how stimulation is delivered , which influences: Which protocols a clinic can offer ( standard rTMS , iTBS/Theta Burst, accelerated/One-Day schedules). Session length ( iTBS sessions are very short; older rTMS sessions are longer ). Comfort & noise profile (coil shape and pulse characteristics feel different). Which brain targets are practical (some coils stimulate deeper or wider networks)? Administrative and insurance details (some devices have specific FDA indications or coverage histories). Importantly, good clinical outcomes depend more on clinician skill, mapping, and monitoring than on brand alone. Device capability matters - but physician-led mapping, correct dosing, and careful follow-up make the biggest difference. Device types explained (plain language) Conventional rTMS What it does: Delivers focused stimulation to a relatively small cortical area. Patient experience: Brief tapping sensation at the skull; sessions take longer than iTBS. Why clinics use it: Reliable for many standard depression protocols and widely available. iTBS (intermittent Theta-Burst Stimulation) capable devices What it does: Uses very short bursts of stimulation that produce similar biological effects as standard rTMS but in far less time. Patient experience: Sessions can be minutes long instead of 20–30+ minutes. Why it matters: Shorter appointments are often better for scheduling and comfort; many clinics combine iTBS with accelerated schedules. MagVenture (brand) What it is: A widely used manufacturer; some MagVenture systems are commonly used for accelerated/One-Day regimens. Why you’ll hear it: Clinics sometimes mention MagVenture when they offer compressed/accelerated protocols because of that device’s capabilities in certain settings. NeuroStar (brand) What it is: A long-standing, widely used TMS platform with established clinical workflows and FDA clearances for depression. Why you’ll hear it: NeuroStar has substantial real-world data and brand recognition. Deep TMS / H-coil (different coil geometry) What it does: Designed to stimulate broader or deeper brain regions than a figure-8 coil. Patient experience: Similar sensations but designed for different targets; used for certain FDA-cleared indications (i ncluding OCD in some systems ). Why it matters: May be an option when deeper networks are targeted, depending on diagnosis and evidence.
Two medical professionals in blue scrubs administer a TMS therapy treatment to a patient sitting in a reclining chair.
By Sam Clinch April 13, 2026
If you’ve chosen a ONE-Day (single-day) TMS course - about 20 short sessions delivered in one (or sometimes two) tightly scheduled days - it helps to know exactly how the day will flow. This patient-facing itinerary shows a typical hour-by-hour timeline, what the clinic does between sessions, what to pack, and simple tips to manage fatigue so your visit is as comfortable and effective as possible. You’ll arrive for a physician consult and motor-threshold mapping , then remain at the clinic for a block of short stimulation sessions with scheduled comfort breaks and outcome checks; the clinic monitors you closely and provides an end-of-day review and written summary. Sample hour-by-hour ONE-Day schedule (typical) 08:00 – 09:00 - Arrival, registration & physician consult Check in, confirm meds, and medical history. Short physician discussion about goals and safety. Clinic staff review consent and logistics. 09:00 – 10:00 - Motor-threshold mapping (30–60 min) Mapping identifies the stimulation intensity that produces a small motor response and documents coil coordinates. Staff records the exact coil position (so every session is reproducible). 10:00 – 12:30 - Treatment sessions (Block 1: Sessions 1–10) Multiple short stimulations (each session minutes long; setup/reset time between sessions). Comfort breaks every 2–3 sessions. Nursing/tech staff perform quick symptom checks during breaks. 12:30 – 13:30 - Lunch & outcome check A longer rest; the clinician may perform a short outcome measure (PHQ-9/GAD-7) or check vitals. Time to eat, rest, change clothes if desired, and call for support if needed (ride, family). 13:30 – 17:30 - Treatment sessions (Block 2: Sessions 11–20) Continue with scheduled short sessions and short comfort breaks. The team monitors tolerance, symptom scores, and comfort. If mapping or pacing adjustments are needed, the physician may make micro-changes. 17:30 – 18:00 - End-of-day review & discharge plan Clinician reviews outcome checks, documents the map and dose, and provides a written summary. The team discusses next steps: maintenance, boosters, and scheduling follow-up. Alternative: 1–2 day split - Many patients choose sessions 1–10 on Day 1 and 11–20 on Day 2 to reduce fatigue. The clinic will recommend this based on your history and tolerance. What the clinic does between sessions While you rest, the team is working clinically - not just waiting. Symptom & safety checks: Quick verbal checks, pain comfort ratings, and short outcome items as needed. Documentation: Techs log session parameters, coil coordinates, and any micro-adjustments. Titration µo-adjustments: If a patient reports discomfort or weak responses, the physician may test slight positional or intensity changes. Outcome monitoring: We compare brief score snapshots to baseline to spot early plateau and decide if remapping or pacing changes are required. Support & comfort: Staff provide water, snacks, and a quiet place to rest. They also address anxiety , nausea, or headache immediately.
Four medical staff members in blue scrubs smiling while standing in front of a clinic logo.
By Sam Clinch March 31, 2026
Cost is often the first practical question people ask about One-Day (20-session) and other accelerated TMS options. At Inspire TMS Denver, we treat price transparency as part of clinical care: patients need clear, itemized information to choose the safest, most realistic plan. This guide explains how we build estimates, what coverage looks like for accelerated care, and the payment and financing options we make available. How we build a clear, itemized estimate We prepare estimates the same way we prepare clinical plans - methodically and transparently. An itemized One-Day or accelerated estimate typically lists: Physician consult & safety review (initial consult + med review) Motor-threshold mapping (the clinical calibration before treatment) Treatment sessions (number of sessions, e.g., 20 for a One-Day plan) Monitoring & outcome tracking (score collection, nursing/tech time) Post-treatment follow-up (clinical review, summaries, maintenance planning) Administrative fees (benefits checks, prior authorization support) Any optional items (travel planning support, printed clinician summaries, extra clinician time) We run a benefits check first so the itemized estimate reflects what your insurer will cover and what your likely out-of-pocket responsibility will be. The result is a one-page, line-item document you can use to compare options, plan travel, or request approval from a third party (employer, caregiver, etc.). Typical cost examples & context Costs vary by protocol ( iTBS vs. standard rTMS vs. One-Day) and local pricing. Historically, clinics have published example One-Day packages as a single bundled price; Inspire’s prior examples of accelerated offerings have been in the mid-range of market pricing (clinic examples published previously showed accelerated options around $7,000 versus higher-priced comparators). These are illustrative - we always produce a current, personalized itemized estimate after the benefits check, so you know what applies to your plan. Insurance & coverage realities for accelerated care Standard coverage: Most insurers that cover TMS cover standard, daily courses for treatment-resistant depression when medical criteria are met and prior authorization has been secured. Accelerated/One-Day nuance: True One- Day 20-session packages are often self-pay because many policies don’t yet recognize compressed, single-day regimens as a standard benefit. However, some insurers - and Medicare in certain situations - do cover modified accelerated patterns (for example, two sessions per day) when clinically justified. We run benefits checks to determine exactly how your plan treats accelerated options. Prior authorization & documentation: When coverage is possible, we submit clinical summaries, prior treatment history, and outcome measures to support authorization. Our team helps with appeals if the initial decision is denied. Learn More: Pricing
A patient in a treatment chair receives TMS therapy as a practitioner adjusts the device near their head.
By Sam Clinch March 30, 2026
The period following completion of an i nitial TMS course is critical . At Inspire TMS Denver , we think of the first 90 days as the window when early gains are consolidated, problems are caught early, and long-term plans (maintenance or boosters) are agreed upon. This practical roadmap explains what clinicians monitor, when a booster or maintenance plan is recommended, and what patients can do to protect and extend benefit. Why the first 90 days matter TMS causes brain-level changes that unfold over weeks . Some people improve quickly and continue to get better; others show delayed responses or need a small clinical adjustment to translate early signals into durable benefit. The first 90 days are when clinicians can: Detect early response vs plateau Make targeted adjustments (remap, pacing, or protocol change) Decide whether boosters or a maintenance schedule will help sustain gains. A proactive, measured approach during this window reduces the chance that patients drift away from care when benefit is still within reach. What clinicians routinely measure and why At Inspire, we rely on objective signals plus clinical judgment. The core things we track are: 1. Standard outcome scores (weekly → monthly) PHQ-9 for depression , GAD-7 for anxiety , and other condition-specific scales. These reveal numeric trends that often precede clear subjective change. We typically collect baseline scores, then repeat them weekly (early weeks), moving to biweekly/monthly checks as things stabilize. 2. Functional markers Sleep, work/school performance, social engagement, and daily activities are measured via short checklists. Function often improves alongside symptom scores - sometimes even earlier. 3. Safety & tolerability Headache, scalp discomfort, fatigue, and any neuro symptoms. Persistent or new neurological issues trigger urgent review. 4. Medication, sleep, and life events Changes in meds, poor sleep, or acute stress/medical events strongly affect response and are always reviewed. 5. Treatment adherence & session data Missed sessions, pacing changes, or protocol deviations are tracked because they affect outcomes.
Modern medical office waiting room with a yellow reception desk, tan tufted sofa, blue armchair, and patterned rug.
By Sam Clinch March 30, 2026
If you live in Boulder or the nearby Front Range and are considering TMS , Inspire TMS Denver in Broomfield is an easy, physician-led option for local care and short-trip accelerated plans. Below you’ll find practical local details - approximate drive times, One-Day logistics, hotel & travel tips, and how to get a no-surprise, itemized estimate for your visit. Why Boulder residents come to Inspire TMS Denver Physician-led care: Dr. Samuel Clinch personally oversees mapping and accelerated One-Day courses. Precision mapping: We perform motor-threshold mapping before any accelerated plan so dose and coil position are individualized. One-Day capability: For patients who need fast delivery of the full course, we offer physician-supervised One-Day (20 sessions in 1–2 days) and other accelerated protocols. Outcome tracking & follow-up: We monitor PHQ-9/GAD-7 scores and make data-driven adjustments (remap, pacing, boosters) so your trip produces measurable results.
A team of four medical professionals in blue scrubs posing in front of an Inspire TMS Denver office logo.
By Sam Clinch March 30, 2026
Mapping is the clinical step that makes TMS precise. At Inspire TMS Denver, we use motor-threshold mapping to find the coil position and stimulation intensity that reliably affect the brain area we intend to treat. But mapping is not a one-and-done ritual - sometimes a fresh map is the right next step. Remapping is a normal, evidence-based part of precision care: it helps the team fine-tune treatment so sessions are safer, more reproducible, and more likely to work. Below is a clear explanation of why we remap, the remapping process, what patients experience, and real examples of how small changes can produce meaningful clinical gains. Why remap? The clinical reasons We commonly consider remapping after a careful review when any of the following apply: Early plateau or slow progress. If outcome scores (PHQ-9, GAD-7, or other scales) stop improving by the expected window (often around week 3), remapping helps determine whether coil position or intensity is limiting response. Prior TMS elsewhere. If you had TMS with a different device or clinic, anatomical and equipment differences can mean that a new, clinic-specific map improves reproducibility. Medication or medical changes. New medications, dose changes, or medical events that affect cortical excitability can change how your brain responds to stimulation. Change of protocol. Moving from standard rTMS to an accelerated plan, One-Day course, or iTBS may warrant a fresh map to ensure safe and effective dosing. Persistent discomfort or side effects. If you have repeated intolerable scalp discomfort or side effects that suggest coil angle/placement could be optimized, remapping is a logical fix. Equipment or technician change. Different coils or small technique differences can alter the effective stimulation; remapping restores precision. Importantly: remapping is not an admission of failure . It’s a targeted diagnostic step - think of it like recalibrating a medical device to match your brain’s current physiology. What happens during a remap? Comfort: You may feel brief tapping and small muscle twitches during mapping; discomfort is usually minimal. Adjustment period: If we change your dose or target, we monitor closely for comfort and early response. Timeline to effect: A beneficial remap sometimes produces earlier improvement in the following weeks, but improvements still unfold over days to weeks. Documentation: You’ll receive an updated map summary that you can share with other providers.
Smiling man in blue scrubs stands near a reception desk with a “Inspire TMS Denver” sign.
By Sam Clinch March 30, 2026
If you completed a One-Day (single-day) TMS course at Inspire - roughly 20 short sessions delivered in one (or two) tightly scheduled days - you’ve taken a fast, physician-supervised step toward change. This week-by-week roadmap explains typical recovery, the symptom signals we watch for, and exactly when to contact the clinic so you get the support you need. Quick reminder - What Happened That Day Your One-Day visit began with a physician consult and motor-threshold mapping , so dose and coil position were tailored to your brain. The day was paced with comfort breaks and outcome checks; you left with an end-of-day summary and follow-up plan. That mapping and documentation allow us to make data-driven decisions after you go home. Week 0 - The Day of Treatment (Immediate Recovery) Expect: Mild scalp soreness or tapping at the coil site, possible brief headache or fatigue by evening. Tips: Rest as needed, hydrate, and eat a normal meal. Avoid alcohol for 24 hours. Arrange a ride home if you feel tired. Call if: Severe symptoms (worsening headache, confusion, fainting). Week 1 - First Signals Expect: Some people notice early changes in sleep, anxiety, or mood; others notice little yet - both are normal. Mild side effects usually resolve. Clinic check: We compare your Week 1 outcome score to your baseline to assess early improvement. Call if: Side effects persist or you feel markedly worse. Read About: Pros & Cons Week 2 - Emerging Pattern Expect: Many patients begin to report clearer improvements (more energy, better sleep, less worry); responses vary. Clinic check: We repeat measures (e.g., PHQ-9) and review meds or sleep if improvement is limited. Call if: You’re concerned you’re not improving, or side effects interfere with daily life.
Woman in blue scrubs using a device on a patient's head. White towel, window with green trees.
By Sam Clinch February 17, 2026
Patients tell us the same thing again and again in reviews: they want clear evidence that treatment is working. At Inspire TMS Denver, we take that request literally - we don’t rely on impressions alone. We measure, record, and act on standardized outcome scores (like the PHQ-9) so every treatment decision is informed by data. That’s why our clinic reviews - the patient stories and high ratings you see online - are paired with hard numbers in our records: we translate “I feel better” into measurable change, and we use those numbers to shape treatment, follow-up, and long-term care. Why measurement matters TMS is powerful because it changes brain circuits. But brain change doesn’t always track neatly with how someone says they feel, especially early in treatment. Standardized scales give clinicians a consistent, sensitive way to detect meaningful clinical change, monitor safety, and decide whether to continue, adjust, or remap a course. At Inspire, we routinely use validated tools ( most commonly the PHQ-9 for depression, and condition-specific measures where appropriate ) before treatment, during the course, and at follow-up. These measures let us answer the crucial questions: Is the patient improving, and by how much? Is the current protocol producing the expected signal? Do we need to remap, change pacing, or offer a maintenance/rescue plan? Collecting and reviewing scores is not paperwork - it is how we turn patient experience into reproducible clinical decisions. What your scores actually mean (PHQ-9 primer) A few PHQ-9 facts are useful for patients: PHQ-9 range: 0–27. Lower is better. Common interpretive bands: 0–4 (minimal), 5–9 (mild), 10–14 (moderate), 15–19 (moderately severe), 20–27 (severe). Clinical response is often defined as a ≥50% reduction in PHQ-9 score from baseline; remission is typically a score in the minimal or near-minimal range. These guidelines let clinicians quantify improvement and compare progress across visits. Research and clinic reports commonly show robust response and remission rates when TMS is delivered to completion - published and clinic-level data often cite response rates in the 60–75% range and remission rates approaching ~45–51% among full-course completers. Those benchmarks help us set realistic expectations and evaluate our own results. How Inspire uses scores day-to-day Here’s how outcome tracking informs care at Inspire: Baseline & goals. We collect a baseline PHQ-9 (and other relevant scales). Dr. Clinch and the team set realistic targets and timelines — e.g., a 50% score reduction by week 4–6 — and share those with the patient. Frequent measurement. We repeat scores at scheduled intervals during treatment (weekly or at clinically meaningful points) so we can detect early signals that predict longer-term response. Data-driven adjustments. If scores plateau or worsen, we don’t guess - we review: does mapping need refinement? Is a medication interaction or a sleep problem present? Should we change protocol pacing, remap, or consider a rescue/maintenance plan? Remapping or protocol changes are common, evidence-driven steps when the data suggest they’re needed. Shared results & transparency. We show patients their numbers over time so they can see the progress (or lack of it) and participate in decisions. This transparency is part of why many patients report a better experience at Inspire - they understand how clinical choices are made and why. Outcome scores and patient reviews - how they match up Patient reviews are invaluable : they capture nuance, meaning, and quality of experience. But reviews are subjective and influenced by many non-clinical factors (appointment flow, staff warmth, travel ease). Outcome tracking gives a reproducible, objective counterpart. At Inspire, we regularly compare patient-reported outcomes with review themes. When a patient posts a high-rating review that mentions life improvements, we can show the corresponding PHQ-9 change in the record. Conversely, when review feedback suggests a problem (e.g., persistent symptoms or side effects), our scores often highlight the clinical trajectory that underlies that feedback. This two-way verification - reviews and scores - helps us continuously improve care and confirms that good experience usually follows measurable clinical benefit.
Medical professional uses a device on a patient's head in a brightly lit room with a window.
By Sam Clinch February 17, 2026
Many patients who want fast, effective relief from depression or other treatment-resistant conditions are exploring accelerated options such as One-Day (single-day) TMS or multi-session compressed courses. At Inspire TMS Denver, we see people travel here from across the U.S. - and the reasons are consistent: physician supervision, precise mapping, documented outcomes, and a patient-first approach to logistics and cost transparency. Below, we explain why patients choose Inspire, what acceleration truly means in practice, how much it costs, what to expect when you travel, and what the data and patient reports say about outcomes. Physician-led care & precise mapping - why it matters What differentiates an excellent accelerated program from a risky one is medical leadership and measurement. Before any accelerated course (including One-Day plans), Inspire requires a physician consult and motor-threshold mapping so dose and coil positioning are individualized to each person’s brain. That mapping step is essential: it sets a reproducible intensity, identifies the optimal coil position, and reduces safety risk - especially important when many sessions are delivered close together. Inspire’s model is explicitly physician-led and mapping-driven, which is why many patients choose it for compressed courses. For One-Day options, mapping and physician oversight are non-negotiable - delivering many sessions in a short window amplifies the effect of any misplacement or incorrect dose, so the clinic’s careful documentation and repeatability matter. Costs - what patients actually see Cost is often the first practical question. Accelerated One-Day packages are frequently offered as self-pay or sliding-scale options because many insurers do not yet cover highly compressed 20-session single-day packages. That said, Inspire has used transparent, example pricing in its content (historical comparison in clinic materials highlighted an Inspire accelerated offering at about $7,000 versus a higher example clinic at $12,500), and the team provides itemized estimates after benefits checks so patients understand their out-of-pocket responsibility before committing. Important insurance nuance: some payers - including Medicare and some commercial plans such as Cigna in certain circumstances - now cover modified accelerated patterns (for example, two sessions per day), which can make faster schedules more affordable when coverage applies. Inspire runs a benefits check and explains which accelerated options are likely to be covered and which will be self-pay. How Inspire helps with cost transparency Benefits check & itemized estimate before any scheduling. Sliding scale or financing options are discussed when appropriate. Clear comparison of standard vs accelerated cost and the difference in clinic time/commitment. Logistics & travel - how Inspire supports out-of-town patients A large share of One-Day and accelerated patients travel to Inspire because of the clinic’s physician supervision and documented experience. Inspire treats travel logistics as part of care: the clinic helps patients plan scheduling, suggests lodging and timing, and provides a clinician-written summary to bring home to local providers. Patients are advised to pack comfort items, chargers, and a current medication list to speed consults and mapping. Typical One-Day practicalities Expect a long but well-paced clinic day (often 8–12+ hours including consult, mapping, and multiple sessions). Bring photo ID, insurance card, a medication list, comfortable clothes, snacks, and a plan for rest after the day. The clinic gives a summary of mapping and outcomes you can share with your prescribing clinician.
Man in blue scrubs stands in front of the reception desk at Inspire TMS Denver.
By Sam Clinch February 17, 2026
When patients ask what makes TMS precise, the answer is: mapping . At Inspire TMS Denver, Dr. Samuel Clinch and the team treat mapping not as a quick formality but as the clinical step that determines where we stimulate and how strongly - two things that have a direct effect on outcomes. Below, we walk through what mapping is, why it matters, how small changes can improve results, and what patients can expect when Dr. Clinch creates their individualized TMS map. What is motor-threshold mapping - and why do we do it? Motor-threshold mapping is the clinical process used to find the stimulation intensity and the precise coil position that reliably activates a known brain response (usually a small, measurable twitch of a hand muscle). That response tells the team how much magnetic energy reaches the brain at a given location and helps set a safe, effective dose for therapeutic targets. Mapping lets us: Personalize the dose. Everyone’s skull thickness, cortical anatomy, and responsiveness are different; motor-threshold mapping determines the appropriate stimulation intensity for your brain. Find the best coil location. Small shifts in coil position or angle change, which brain circuits get stimulated - mapping helps us locate the spot that best connects to the circuit we want to influence. Increase safety and predictability. Mapping is performed before any therapeutic session (standard or accelerated ), so we deliver a dose matched to your physiology, reducing risk and improving reproducibility. Dr. Clinch’s clinical priorities during mapping Dr. Clinch’s mapping approach emphasizes three things: precision, comfort, and context. Precision: mapping is done by a clinician-trained team under physician oversight, so coil position and intensity are documented and repeatable. This means we don’t “guess” - we measure and record. Comfort: mapping and initial sessions are paced with patient comfort in mind. If a patient is anxious or uncomfortable, we adjust breaks and pacing while maintaining diagnostic integrity. Contextual decision-making: Dr. Clinch interprets mapping data in the context of a patient’s history, current medications, prior TMS (if any), and treatment goals. That lets him recommend standard vs. accelerated schedules, conservative dosing for medically complex patients, or remapping when prior TMS results change. How small changes in coil position or dose matter It’s tempting to think “a few millimeters won’t change much,” but in TMS , a small positional or angle change can alter which connected brain circuit receives the strongest stimulation. Practically: A slight anterior/posterior shift may move stimulation onto cells with different functional connections. A small rotation of the coil changes the vector of induced current and can alter effectiveness or side-effect profile. A modest intensity adjustment (a few percent of motor threshold) can change how reliably synaptic pathways are recruited. Because of this sensitivity, the Inspire team documents coil coordinates and intensity on every mapping so treatment sessions reproduce the same physiological conditions each time. If outcomes aren’t as expected, the team often remaps and makes micro-adjustments - a step that frequently clarifies whether dose or position needs refinement.
Show More